AlphaGrep UK Ltd

Position in ABBV — AbbVie Inc.

CIK 2148988 London, X0

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$216,410

-$87,858 QoQ

Shares Held

860

-38.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#3,912

of 4,152 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AlphaGrep UK Ltd holds $2,660,313 across 6 Drug Manufacturers - General names. ABBV ranks #6 (8.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	710	$851,595
2	GILD	Gilead Sciences, Inc.	5,212	$658,484
3	BMY	Bristol Myers Squibb Co	7,606	$438,257
4	AMGN	Amgen Inc	731	$264,709
5	JNJ	Johnson & Johnson	909	$230,858
6	ABBV	AbbVie Inc. This page	860	$216,410

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$216,410	860	-38.5%	Shares	Sole	2026-08-14
2026-03-31	$304,268	1,399	-55.4%	Shares	Sole	2026-08-13
2025-12-31	$717,458	3,140	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.